Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden · Delayed Price · Currency is SEK 12.85
-0.10 (-0.77%)
Jun 11, 2026, 5:03 PM CET
STO:ANNX Market Cap
STO:ANNX has a market cap or net worth of 90.71 million as of June 11, 2026. Its market cap has decreased by -66.08% in one year.
Market Cap
90.71M
Enterprise Value
73.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.85
Market Cap Chart
Since April 19, 2017, STO:ANNX's market cap has increased from 50.21M to 90.71M, an increase of 80.66%. That is a compound annual growth rate of 6.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 91.42M | -34.60% |
| Dec 30, 2025 | 139.77M | -39.44% |
| Dec 30, 2024 | 230.78M | 161.10% |
| Dec 29, 2023 | 88.39M | -42.68% |
| Dec 30, 2022 | 154.19M | 12.35% |
| Dec 30, 2021 | 137.24M | 9.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alligator Bioscience AB | 126.88M |
| NextCell Pharma AB | 120.30M |
| Simris Group AB (PUBL) | 116.62M |
| Biovica International AB | 105.67M |
| IRLAB Therapeutics AB | 105.32M |
| OncoZenge AB | 99.60M |
| AcouSort AB | 95.87M |
| Scandinavian ChemoTech AB | 92.14M |